Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunity during cyclosporine therapy.

H Valdimarsson1

  • 1Department of Immunology, University of Iceland, Reykjavik.

Journal of the American Academy of Dermatology
|December 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytes.

Immunology today·2014
Same author

The role of Th17/Tc17 peripheral blood T cells in psoriasis and their positive therapeutic response.

Scandinavian journal of immunology·2013
Same author

The association of sore throat and psoriasis might be explained by histologically distinctive tonsils and increased expression of skin-homing molecules by tonsil T cells.

Clinical and experimental immunology·2013
Same author

The role of the palatine tonsils in the pathogenesis and treatment of psoriasis.

The British journal of dermatology·2012
Same author

Seasonal changes in migratory and predatory activity of two species of gadoid preying on inshore northern shrimp Pandalus borealis.

Journal of fish biology·2011
Same author

Immunological studies in chronic granulomatous candidiasis and the effect of treatment with dialysable transfer factor.

Archives of disease in childhood·2010
Same journal

"Highlights from JAAD International: Noninvasive imaging for basal cell carcinoma".

Journal of the American Academy of Dermatology·2026
Same journal

Effect of Primary Prophylaxis for Pneumocystis Pneumonia in Patients on Rituximab for Immune-Mediated Dermatologic Conditions: A Systematic Review and Meta-Analysis.

Journal of the American Academy of Dermatology·2026
Same journal

Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension study.

Journal of the American Academy of Dermatology·2026
Same journal

Real-World Effectiveness and Safety of Ritlecitinib in Adolescents with Severe Alopecia Areata: A 36-Week Single-Center Study.

Journal of the American Academy of Dermatology·2026
Same journal

Liquid Biopsy in Cutaneous Oncology: Current Practice and Future Directions.

Journal of the American Academy of Dermatology·2026
Same journal

Ethically protecting immunosuppressed patients in shared dermatology spaces.

Journal of the American Academy of Dermatology·2026
See all related articles

Cyclosporine inhibits immune memory but is reversible, unlike cytotoxic drugs that cause permanent loss. Cyclosporine monotherapy may increase cancer risk, particularly in psoriasis patients previously treated with PUVA or methotrexate.

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Cyclosporine, an immunosuppressant, inhibits CD4+ T lymphocyte growth factors and immune reactions.
  • Unlike cytotoxic agents, cyclosporine's effects are largely reversible, with immune competence returning post-treatment.
  • Conventional immunosuppressants can cause permanent loss of immunologic memory due to T-lymphocyte clone deletion.

Purpose of the Study:

  • To compare the long-term immunologic effects of cyclosporine versus conventional cytotoxic immunosuppressive agents.
  • To investigate the potential association between cyclosporine monotherapy and increased cancer incidence.
  • To identify patient subgroups potentially at higher risk for tumors during cyclosporine treatment.

Main Methods:

  • Review of existing literature on cyclosporine and conventional immunosuppressive drug effects on immune memory.

Related Experiment Videos

  • Analysis of cancer incidence reports in patients treated with cyclosporine alone versus in combination therapy.
  • Comparative assessment of T-lymphocyte clone deletion and immune restoration capabilities.

    • Main Results:

    • Cyclosporine does not cause cytotoxic effects or permanent immunologic memory loss.
    • Combination therapy with cyclosporine and conventional agents may increase the risk of non-Hodgkin's lymphoma and endocrine tumors.
    • No increased cancer incidence observed in patients treated with cyclosporine monotherapy for psoriasis or autoimmune diseases.

    Conclusions:

    • Cyclosporine offers a reversible immunosuppressive profile, preserving immunologic memory unlike cytotoxic drugs.
    • The risk of increased cancer incidence with cyclosporine monotherapy is predicted to be low, potentially affecting specific patient groups like psoriasis patients post-PUVA/methotrexate.
    • Further studies comparing cancer incidence across different patient categories are needed to fully resolve the issue of cyclosporine and tumorigenesis.